Correction to: Pathophysiology of and therapeutic options for a GABRA1 variant linked to epileptic encephalopathy

Mol Brain. 2020 Mar 27;13(1):50. doi: 10.1186/s13041-020-00593-6.

¹ Djavad Mowafaghian Centre for Brain Health and Department of Medicine, University of British Columbia, Vancouver, Canada.
² Department of Neurobiology, Beijing Key Laboratory of Neural Regeneration and Repair, Beijing Laboratory of Brain Disorders (Ministry of Science and Technology), Beijing Institute for Brain Disorders, Capital Medical University, Beijing, China.
³ Division of Neurology, Department of Paediatrics, BC Children's Hospital, University of British Columbia, Vancouver, Canada.
⁴ Centre for Applied Neurogenetics, University of British Columbia, Vancouver, Canada.
⁵ McKnight Brain Institute, University of Florida, Gainesville, USA.
⁶ Djavad Mowafaghian Centre for Brain Health and Department of Medicine, University of British Columbia, Vancouver, Canada. lidong@mail.ubc.ca.
⁷ Division of Neurology, Department of Paediatrics, BC Children's Hospital, University of British Columbia, Vancouver, Canada. mdemos@cw.bc.ca.
⁸ Djavad Mowafaghian Centre for Brain Health and Department of Medicine, University of British Columbia, Vancouver, Canada. ytwang@brain.ubc.ca.

Abstract

Following publication of the original article [1], the authors reported errors in Figure 4.